(Q44700353)

5 December 2017

Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes (English)

1 reference

Hormone Replacement Therapy

5 December 2017

1 reference

A R Scott

1

1 reference

5 December 2017

P Dhindsa

2

1 reference

5 December 2017

J Forsyth

3

1 reference

5 December 2017

P Mansell

4

1 reference

5 December 2017

Kliofem Study Collaborative Group

5

1 reference

5 December 2017

1 January 2004

1 reference

Diabetes, Obesity and Metabolism

5 December 2017

1 reference

5 December 2017

6

1 reference

5 December 2017

1

1 reference

5 December 2017

16-22

1 reference

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

5 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

The effects of hormone replacement therapy on plasma lipids in type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Vascular effects of estrogen in type II diabetic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Menopause and risk of cardiovascular disease: the Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Hormone replacement therapy, heart disease, and other considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Hormone replacement therapy in type 2 diabetes mellitus: a cardiovascular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

Diabetes and cardiovascular risk factors: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00294.X

10.1111/J.1463-1326.2004.00294.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference